Stefan Gustavsen

468 total citations
19 papers, 327 citations indexed

About

Stefan Gustavsen is a scholar working on Pathology and Forensic Medicine, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Stefan Gustavsen has authored 19 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 7 papers in Pharmacology and 5 papers in Psychiatry and Mental health. Recurrent topics in Stefan Gustavsen's work include Multiple Sclerosis Research Studies (11 papers), Cannabis and Cannabinoid Research (7 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers). Stefan Gustavsen is often cited by papers focused on Multiple Sclerosis Research Studies (11 papers), Cannabis and Cannabinoid Research (7 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers). Stefan Gustavsen collaborates with scholars based in Denmark, United States and Sweden. Stefan Gustavsen's co-authors include Finn Sellebjerg, Helle Bach Søndergaard, Anna Olsson, Annette Oturai, Annika Reynberg Langkilde, Per Soelberg Sørensen, Tue H. Hansen, Melinda Magyari, Thao Duy Nguyen and Henrik Ullum and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Journal of Neurology.

In The Last Decade

Stefan Gustavsen

17 papers receiving 321 citations

Peers

Stefan Gustavsen
Stefan Gustavsen
Citations per year, relative to Stefan Gustavsen Stefan Gustavsen (= 1×) peers Isabel Pastor

Countries citing papers authored by Stefan Gustavsen

Since Specialization
Citations

This map shows the geographic impact of Stefan Gustavsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Gustavsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Gustavsen more than expected).

Fields of papers citing papers by Stefan Gustavsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Gustavsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Gustavsen. The network helps show where Stefan Gustavsen may publish in the future.

Co-authorship network of co-authors of Stefan Gustavsen

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Gustavsen. A scholar is included among the top collaborators of Stefan Gustavsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Gustavsen. Stefan Gustavsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Olsson, Anna, Stefan Gustavsen, Annika Reynberg Langkilde, et al.. (2025). Profiling of Epstein-Barr Virus microRNAs in Whole Blood and Exosomes in Multiple Sclerosis. Immunological Investigations. 54(8). 1524–1541.
2.
Søndergaard, Helle Bach, Anna Olsson, Stefan Gustavsen, et al.. (2024). Neurofilament light in serum: Reference values and effect of risk factors for multiple sclerosis. Multiple Sclerosis and Related Disorders. 92. 106166–106166. 5 indexed citations
3.
Giossi, Riccardo, Massimo Filippi, Chiara Zanetta, et al.. (2024). Unprescribed cannabinoids and multiple sclerosis: a multicenter, cross-sectional, epidemiological study in Lombardy, Italy. Journal of Neurology. 271(11). 7186–7205.
4.
Boix, Fernando, Jørgen Bo Hasselstrøm, Lambert K. Sørensen, et al.. (2023). Pharmacokinetics and pharmacodynamics of cannabis‐based medicine in a patient population included in a randomized, placebo‐controlled, clinical trial. Clinical and Translational Science. 17(1). e13685–e13685. 11 indexed citations
5.
Gustavsen, Stefan, Anna Olsson, Annette Oturai, et al.. (2023). The peripheral endocannabinoid system and its association with biomarkers of inflammation in untreated patients with multiple sclerosis. European Journal of Neurology. 30(10). 3212–3220. 4 indexed citations
6.
Gustavsen, Stefan, et al.. (2023). Acute disseminated encephalomyelitis following the COVID-19 vaccine Ad26.COV2.S, a case report. SHILAP Revista de lepidopterología. 47(1). 5–5. 4 indexed citations
7.
Gustavsen, Stefan, Homayoun Roshanisefat, Matthias Kant, et al.. (2023). Cannabis-Based Medicine for Neuropathic Pain and Spasticity—A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial. Pharmaceuticals. 16(8). 1079–1079. 14 indexed citations
8.
Olsson, Anna, Stefan Gustavsen, Thao Duy Nguyen, et al.. (2021). Serum Short-Chain Fatty Acids and Associations With Inflammation in Newly Diagnosed Patients With Multiple Sclerosis and Healthy Controls. Frontiers in Immunology. 12. 661493–661493. 73 indexed citations
9.
Olsson, Anna, et al.. (2021). Neutrophil‐to‐lymphocyte ratio and CRP as biomarkers in multiple sclerosis: A systematic review. Acta Neurologica Scandinavica. 143(6). 577–586. 34 indexed citations
10.
Olsson, Anna, et al.. (2021). MRI of the Entire Spinal Cord—Worth the While or Waste of Time? A Retrospective Study of 74 Patients with Multiple Sclerosis. Diagnostics. 11(8). 1424–1424. 2 indexed citations
11.
Gustavsen, Stefan, et al.. (2021). The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report survey. BMC Neurology. 21(1). 317–317. 41 indexed citations
12.
Olsson, Anna, Stefan Gustavsen, Annika Reynberg Langkilde, et al.. (2021). Circulating levels of tight junction proteins in multiple sclerosis: Association with inflammation and disease activity before and after disease modifying therapy. Multiple Sclerosis and Related Disorders. 54. 103136–103136. 29 indexed citations
14.
Olsson, Anna, Stefan Gustavsen, Annika Reynberg Langkilde, et al.. (2020). Biomarkers of inflammation and epithelial barrier function in multiple sclerosis. Multiple Sclerosis and Related Disorders. 46. 102520–102520. 15 indexed citations
15.
Gustavsen, Stefan, et al.. (2020). Safety and efficacy of low-dose medical cannabis oils in multiple sclerosis. Multiple Sclerosis and Related Disorders. 48. 102708–102708. 8 indexed citations
16.
Søndergaard, Helle Bach, Nils Koch‐Henriksen, Christina Andersen, et al.. (2020). Exposure to passive smoking during adolescence is associated with an increased risk of developing multiple sclerosis. Multiple Sclerosis Journal. 27(2). 188–197. 13 indexed citations
17.
Gustavsen, Stefan, et al.. (2019). Illegal cannabis use is common among Danes with multiple sclerosis. Multiple Sclerosis and Related Disorders. 33. 5–12. 17 indexed citations
18.
Andersen, Christina, Helle Bach Søndergaard, Julie Laursen, et al.. (2018). Alcohol consumption in adolescence is associated with a lower risk of multiple sclerosis in a Danish cohort. Multiple Sclerosis Journal. 25(12). 1572–1579. 22 indexed citations
19.
Gustavsen, Stefan, Helle Bach Søndergaard, Bjarne Laursen, et al.. (2016). Shift work at young age is associated with increased risk of multiple sclerosis in a Danish population. Multiple Sclerosis and Related Disorders. 9. 104–109. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026